OR WAIT null SECS
September 21, 2022
Lonza has expanded its HPAPI multipurpose suite for payload-linker manufacturing.
Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.
September 20, 2022
Regulatory officials are addressing challenges in ensuring that clinical data can be relied on in making regulatory decisions.
CytoReason has announced an expanded collaboration deal with Pfizer to deliver AI for drug discovery and development.
Otsuka announced that the EC has approved Lupkynis as the first oral treatment for active lupus nephritis.
September 19, 2022
Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility.
Novo Nordisk and Microsoft are collaborating to accelerate drug discovery and development using big data and artificial intelligence.
Ensysce Biosciences and Quotient Sciences are partnering to develop and test Ensysce’s novel opioid designed to prevent abuse and overdose.
September 16, 2022
EMA has recommended approval of Enjaymo for the treatment of hemolytic anemia in adult patients with cold agglutinin disease.
The White House hopes to expand US modern biotech manufacturing and reduce reliance on foreign sources of bioindustrial materials.